Cargando…

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY

Detalles Bibliográficos
Autores principales: Gonzalez-Calle, Veronica, Rodríguez-Otero, Paula, Sureda, Anna, de la Fuente, Felipe de Arriba, Reinoso Segura, Marta, Ribas, Paz, Pilar Gonzalez, Ana, Gonzalez Montes, Yolanda, Oriol, Albert, Martinez-Lopez, Joaquín, Perez, Marta Sonia Gonzalez, Garcia, Miguel Teodoro Hernandez, Sirvent Auzmendi, Maialen, Blade, Joan, Palacios, Juan José Lahuerta, San Miguel, Jesús, Mateos, Maria-Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431021/
http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c
_version_ 1785091100006940672
author Gonzalez-Calle, Veronica
Rodríguez-Otero, Paula
Sureda, Anna
de la Fuente, Felipe de Arriba
Reinoso Segura, Marta
Ribas, Paz
Pilar Gonzalez, Ana
Gonzalez Montes, Yolanda
Oriol, Albert
Martinez-Lopez, Joaquín
Perez, Marta Sonia Gonzalez
Garcia, Miguel Teodoro Hernandez
Sirvent Auzmendi, Maialen
Blade, Joan
Palacios, Juan José Lahuerta
San Miguel, Jesús
Mateos, Maria-Victoria
author_facet Gonzalez-Calle, Veronica
Rodríguez-Otero, Paula
Sureda, Anna
de la Fuente, Felipe de Arriba
Reinoso Segura, Marta
Ribas, Paz
Pilar Gonzalez, Ana
Gonzalez Montes, Yolanda
Oriol, Albert
Martinez-Lopez, Joaquín
Perez, Marta Sonia Gonzalez
Garcia, Miguel Teodoro Hernandez
Sirvent Auzmendi, Maialen
Blade, Joan
Palacios, Juan José Lahuerta
San Miguel, Jesús
Mateos, Maria-Victoria
author_sort Gonzalez-Calle, Veronica
collection PubMed
description
format Online
Article
Text
id pubmed-10431021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310212023-08-17 P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY Gonzalez-Calle, Veronica Rodríguez-Otero, Paula Sureda, Anna de la Fuente, Felipe de Arriba Reinoso Segura, Marta Ribas, Paz Pilar Gonzalez, Ana Gonzalez Montes, Yolanda Oriol, Albert Martinez-Lopez, Joaquín Perez, Marta Sonia Gonzalez Garcia, Miguel Teodoro Hernandez Sirvent Auzmendi, Maialen Blade, Joan Palacios, Juan José Lahuerta San Miguel, Jesús Mateos, Maria-Victoria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431021/ http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Gonzalez-Calle, Veronica
Rodríguez-Otero, Paula
Sureda, Anna
de la Fuente, Felipe de Arriba
Reinoso Segura, Marta
Ribas, Paz
Pilar Gonzalez, Ana
Gonzalez Montes, Yolanda
Oriol, Albert
Martinez-Lopez, Joaquín
Perez, Marta Sonia Gonzalez
Garcia, Miguel Teodoro Hernandez
Sirvent Auzmendi, Maialen
Blade, Joan
Palacios, Juan José Lahuerta
San Miguel, Jesús
Mateos, Maria-Victoria
P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title_full P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title_fullStr P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title_full_unstemmed P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title_short P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM-SELIBORDARA STUDY
title_sort p878: selinexor in combination with daratumumab-bortezomib and dexamethasone for the treatment of relapse or refractory multiple myeloma: updated results of the phase 2, multicenter gem-selibordara study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431021/
http://dx.doi.org/10.1097/01.HS9.0000970416.95490.2c
work_keys_str_mv AT gonzalezcalleveronica p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT rodriguezoteropaula p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT suredaanna p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT delafuentefelipedearriba p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT reinososeguramarta p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT ribaspaz p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT pilargonzalezana p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT gonzalezmontesyolanda p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT oriolalbert p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT martinezlopezjoaquin p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT perezmartasoniagonzalez p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT garciamiguelteodorohernandez p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT sirventauzmendimaialen p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT bladejoan p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT palaciosjuanjoselahuerta p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT sanmigueljesus p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy
AT mateosmariavictoria p878selinexorincombinationwithdaratumumabbortezomibanddexamethasoneforthetreatmentofrelapseorrefractorymultiplemyelomaupdatedresultsofthephase2multicentergemselibordarastudy